An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Bristol-Myers Squibb
Bristol-Myers Squibb
National Cancer Institute (NCI)
Hackensack Meridian Health
Intensity Therapeutics, Inc.
Stanford University
National Cancer Institute (NCI)